James Molloy
Stock Analyst at Alliance Global Partners
(0.41)
# 4,156
Out of 4,981 analysts
33
Total ratings
23.53%
Success rate
-38.98%
Average return
Main Sectors:
Stocks Rated by James Molloy
Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
---|---|---|---|---|---|---|---|
SNGX Soligenix | Maintains: Buy | $10 → $6 | $2.92 | +105.48% | 1 | Jul 16, 2025 | |
IGC IGC Pharma | Reiterates: Buy | $3.5 | $0.41 | +762.28% | 2 | Mar 6, 2025 | |
INTS Intensity Therapeutics | Initiates: Buy | $8.5 | $0.23 | +3,560.64% | 1 | Jan 13, 2025 | |
VTVT vTv Therapeutics | Initiates: Buy | $35 | $19.76 | +77.13% | 1 | Dec 9, 2024 | |
GOVX GeoVax Labs | Initiates: Buy | $15 | $0.70 | +2,037.06% | 1 | Nov 11, 2024 | |
INMB INmune Bio | Initiates: Buy | $20 | $2.01 | +895.02% | 1 | Oct 21, 2024 | |
SCLX Scilex Holding Company | Initiates: Buy | $490 | $26.28 | +1,764.54% | 1 | Oct 16, 2024 | |
TNXP Tonix Pharmaceuticals Holding | Maintains: Buy | $600 → $1,100 | $28.61 | +3,744.81% | 7 | Jul 22, 2024 | |
PED PEDEVCO | Initiates: Buy | $1.75 | $0.60 | +193.48% | 1 | Jul 17, 2024 | |
PXS Pyxis Tankers | Initiates: Buy | $10 | $2.84 | +252.11% | 1 | Jul 17, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $9 → $14 | $0.83 | +1,594.30% | 2 | Jan 4, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $30 | $1.59 | +1,786.79% | 1 | Dec 11, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $7.5 | $1.22 | +514.75% | 1 | Jul 17, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $20 | $6.43 | +211.04% | 1 | May 24, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $14 → $8 | $1.85 | +332.43% | 1 | Nov 15, 2022 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $10 → $7 | $5.05 | +38.61% | 2 | Nov 4, 2022 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $80 | $0.79 | +10,039.42% | 1 | Nov 1, 2022 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $16 | $0.44 | +3,517.45% | 1 | Nov 1, 2022 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $280 | $4.31 | +6,396.52% | 1 | Oct 20, 2022 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $196 | $5.75 | +3,302.61% | 1 | Oct 13, 2022 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $8,400 | $7.50 | +111,900.00% | 1 | Sep 7, 2022 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $150 | $2.32 | +6,365.52% | 1 | Aug 25, 2022 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $938 | $0.97 | +96,559.45% | 1 | Jun 1, 2022 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $25 | $3.08 | +711.69% | 1 | Oct 4, 2021 |
Soligenix
Jul 16, 2025
Maintains: Buy
Price Target: $10 → $6
Current: $2.92
Upside: +105.48%
IGC Pharma
Mar 6, 2025
Reiterates: Buy
Price Target: $3.5
Current: $0.41
Upside: +762.28%
Intensity Therapeutics
Jan 13, 2025
Initiates: Buy
Price Target: $8.5
Current: $0.23
Upside: +3,560.64%
vTv Therapeutics
Dec 9, 2024
Initiates: Buy
Price Target: $35
Current: $19.76
Upside: +77.13%
GeoVax Labs
Nov 11, 2024
Initiates: Buy
Price Target: $15
Current: $0.70
Upside: +2,037.06%
INmune Bio
Oct 21, 2024
Initiates: Buy
Price Target: $20
Current: $2.01
Upside: +895.02%
Scilex Holding Company
Oct 16, 2024
Initiates: Buy
Price Target: $490
Current: $26.28
Upside: +1,764.54%
Tonix Pharmaceuticals Holding
Jul 22, 2024
Maintains: Buy
Price Target: $600 → $1,100
Current: $28.61
Upside: +3,744.81%
PEDEVCO
Jul 17, 2024
Initiates: Buy
Price Target: $1.75
Current: $0.60
Upside: +193.48%
Pyxis Tankers
Jul 17, 2024
Initiates: Buy
Price Target: $10
Current: $2.84
Upside: +252.11%
Jan 4, 2024
Maintains: Buy
Price Target: $9 → $14
Current: $0.83
Upside: +1,594.30%
Dec 11, 2023
Initiates: Buy
Price Target: $30
Current: $1.59
Upside: +1,786.79%
Jul 17, 2023
Initiates: Buy
Price Target: $7.5
Current: $1.22
Upside: +514.75%
May 24, 2023
Reiterates: Buy
Price Target: $20
Current: $6.43
Upside: +211.04%
Nov 15, 2022
Maintains: Buy
Price Target: $14 → $8
Current: $1.85
Upside: +332.43%
Nov 4, 2022
Maintains: Buy
Price Target: $10 → $7
Current: $5.05
Upside: +38.61%
Nov 1, 2022
Initiates: Buy
Price Target: $80
Current: $0.79
Upside: +10,039.42%
Nov 1, 2022
Initiates: Buy
Price Target: $16
Current: $0.44
Upside: +3,517.45%
Oct 20, 2022
Initiates: Buy
Price Target: $280
Current: $4.31
Upside: +6,396.52%
Oct 13, 2022
Initiates: Buy
Price Target: $196
Current: $5.75
Upside: +3,302.61%
Sep 7, 2022
Initiates: Buy
Price Target: $8,400
Current: $7.50
Upside: +111,900.00%
Aug 25, 2022
Initiates: Buy
Price Target: $150
Current: $2.32
Upside: +6,365.52%
Jun 1, 2022
Initiates: Buy
Price Target: $938
Current: $0.97
Upside: +96,559.45%
Oct 4, 2021
Initiates: Buy
Price Target: $25
Current: $3.08
Upside: +711.69%